Conference Coverage

TCT 2015

See All Content See past conferences

San Francisco

October 11, 2015

October 15, 2015

News Opinion Editor's Corner

My Takeaways From TCT 2015

Last week I was one of the roughly 11,000 people packing into TCT 2015 to watch live-case demonstrations and get breaking results from a host of major clinical trials. This year marked my fifteenth consecutive trip to the annual TCT meeting.

News

News Conference News

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Conference News

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Nicole Lou

October 15, 2015

News Conference News

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

News Conference News

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

October 14, 2015

News Conference News

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

Slides

Presentation

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Martin B. Leon

October 12, 2015

Presentation

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

Presenter: Martin B. Leon

October 12, 2015

Presentation

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Martin B. Leon

October 12, 2015

Presentation

Case Presentations/Taped TAVR Case Segments

Presenter: Marian C. Hawkey

October 11, 2015

All Conference Content

Advertisement

TCT 2015

My Takeaways From TCT 2015

News

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

TWENTE: ZES, EES Convey Similar Safety, Efficacy Results at 5 Years

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Slides

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Case Presentations/Taped TAVR Case Segments

@TCTMD

Advertisement

All Conference Content

Advertisement

TCT 2015

News

Slides

Advertisement

All Conference Content

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

TCT 2015